| Financial Year |
March 31 2023 |
| Monetary Funds |
34,048,655,694.44 |
| Held-for-trading Financial Assets |
3,290.00 |
| Notes Receivable |
1,474,761,540.81 |
| Accounts Receivable |
31,535,348,590.15 |
| Advances to Suppliers |
829,003,499.09 |
| Other Receivables |
2,267,603,076.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
65,695,959.52 |
| Dividend Receivable |
322,860,276.62 |
| Inventories |
22,241,040,289.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
205,255,758.16 |
| Other Current Assets |
1,529,898,088.18 |
| Total Current Assets |
102,240,529,867.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
86,222,962.96 |
| Long-term Equity Investment |
12,467,094,434.71 |
| Investment Properties |
419,806,109.83 |
| Fixed Assetes |
21,999,422,282.91 |
| Under-construction Projects |
3,958,915,187.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,952,549,082.48 |
| R&D expenses |
-- |
| Goodwill |
781,115,081.73 |
| Long-Term Deferred and Prepaid Expenses |
855,668,211.09 |
| Deferred Income Tax Assets |
5,874,200,033.90 |
| Other Non-Current Assets |
450,706,944.99 |
| Sub-Total of Non-Current Assets |
59,218,533,802.98 |
| Total Assets |
161,459,063,670.47 |
| Short-Term Loans |
9,617,432,865.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,427,552,865.40 |
| Accounts Payable |
48,469,227,888.24 |
| Accounts Received In Advance |
12,329,004.34 |
| Employee Compensation Payable |
4,271,862,811.73 |
| Taxes Payable |
1,138,595,075.30 |
| Interest Payable |
4,219,939.10 |
| Dividend Payable |
449,531,880.89 |
| Other payables |
9,490,413,721.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,336,792,093.14 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
91,143,975,352.35 |
| Long-term Loans |
3,523,582,929.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
658,192.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,112,278,707.34 |
| Deferred Income Tax Liabilities |
1,453,651,703.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,257,905,486.90 |
| Total Liabilities |
102,401,880,839.25 |
| Paid-In Capital(Or Share Stock) |
3,152,723,984.00 |
| Capital Surplus |
11,462,793,590.51 |
| Surplus Reserve |
4,750,627,253.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
33,541,936,496.70 |
| Minority Stockholder's Interest |
4,299,810,008.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
54,757,372,823.21 |
| Owner's Equity（Stockholder's Equity） |
59,057,182,831.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
161,459,063,670.47 |
